This is a table of adjective/noun combinations and their frequencies from sentences in your study carrel. Use it to search & browse the list to learn more about your study carrel.
adjective | noun | frequency |
---|---|---|
- | hsct | 1357 |
hematopoietic | stem | 1239 |
- | cell | 1199 |
median | age | 906 |
peripheral | blood | 885 |
overall | survival | 798 |
- | transplant | 735 |
median | time | 524 |
acute | gvhd | 508 |
chronic | gvhd | 507 |
- | cells | 466 |
high | risk | 457 |
- | risk | 413 |
unrelated | donor | 374 |
pediatric | patients | 309 |
hematopoietic | cell | 267 |
autologous | stem | 247 |
unrelated | donors | 227 |
viral | infections | 214 |
acute | graft | 188 |
- | t | 171 |
- | year | 154 |
autologous | hsct | 141 |
chronic | graft | 132 |
post | transplant | 128 |
- | transplantation | 116 |
specific | t | 106 |
post | hsct | 103 |
- | time | 102 |
first | year | 102 |
higher | risk | 92 |
respiratory | infections | 80 |
viral | infection | 77 |
severe | infections | 73 |
autologous | transplantation | 67 |
- | group | 62 |
older | patients | 55 |
low | risk | 54 |
primary | graft | 54 |
median | day | 53 |
- | gvhd | 52 |
peripheral | stem | 52 |
first | time | 51 |
significant | risk | 50 |
- | disease | 50 |
older | age | 50 |
immune | cells | 49 |
positive | cells | 46 |
- | treatment | 43 |
- | infection | 42 |
autologous | transplant | 42 |
immune | cell | 42 |
other | patients | 40 |
median | survival | 39 |
post | transplantation | 39 |
first | case | 38 |
pediatric | hsct | 38 |
first | day | 36 |
positive | patients | 36 |
- | patient | 35 |
- | analysis | 34 |
- | donor | 34 |
different | time | 34 |
hematopoietic | cells | 34 |
primary | disease | 34 |
first | month | 30 |
severe | disease | 30 |
severe | gvhd | 29 |
pediatric | patient | 27 |
other | studies | 27 |
- | therapy | 27 |
clinical | studies | 26 |
lower | risk | 26 |
specific | treatment | 26 |
first | patient | 25 |
other | patient | 25 |
other | infections | 24 |
respiratory | infection | 24 |
positive | blood | 23 |
severe | infection | 23 |
hematopoietic | transplantation | 22 |
median | days | 22 |
- | day | 21 |
- | month | 21 |
normal | t | 21 |
unrelated | hsct | 20 |
respiratory | disease | 20 |
old | patient | 20 |
- | blood | 19 |
clinical | study | 19 |
first | transplant | 19 |
highest | risk | 19 |
- | patients | 18 |
- | years | 18 |
other | groups | 18 |
primary | infection | 18 |
- | survival | 17 |
low | t | 17 |
other | diseases | 16 |
severe | cases | 15 |
severe | graft | 15 |
primary | treatment | 14 |
other | treatment | 14 |
other | day | 14 |
early | treatment | 14 |
- | study | 14 |
chronic | infection | 14 |
autologous | blood | 13 |
early | disease | 13 |
median | patient | 13 |
autologous | t | 13 |
- | transplanted | 12 |
early | hsct | 12 |
first | hsct | 12 |
other | cases | 12 |
positive | results | 12 |
unrelated | stem | 12 |
unrelated | transplant | 12 |
early | age | 11 |
severe | t | 11 |
peripheral | t | 11 |
early | studies | 11 |
different | treatment | 11 |
clinical | results | 11 |
- | days | 11 |
clinical | disease | 11 |
- | graft | 10 |
clinical | risk | 10 |
early | t | 10 |
early | transplant | 10 |
first | study | 10 |
lower | survival | 10 |
specific | therapy | 10 |
unrelated | transplants | 10 |
significant | gvhd | 9 |
other | therapies | 9 |
unrelated | transplantation | 9 |
pediatric | cases | 9 |
high | treatment | 9 |
other | disease | 9 |
first | years | 9 |
different | groups | 9 |
median | cell | 8 |
viral | disease | 8 |
post | treatment | 8 |
normal | donors | 8 |
other | transplant | 8 |
high | survival | 8 |
different | donor | 8 |
chronic | disease | 8 |
autologous | transplants | 8 |
acute | infection | 8 |
median | disease | 7 |
primary | therapy | 7 |
positive | donors | 7 |
pediatric | transplant | 7 |
pediatric | stem | 7 |
pediatric | donors | 7 |
other | donors | 7 |
older | group | 7 |
primary | cells | 7 |
higher | survival | 7 |
high | disease | 7 |
first | group | 7 |
different | times | 7 |
different | donors | 7 |
autologous | donors | 7 |
clinical | case | 7 |
high | transplant | 7 |
median | times | 6 |
viral | diseases | 6 |
unrelated | grafts | 6 |
respiratory | diseases | 6 |
positive | disease | 6 |
positive | cases | 6 |
other | treatments | 6 |
other | risk | 6 |
other | group | 6 |
higher | cell | 6 |
early | group | 6 |
different | cell | 6 |
autologous | patients | 6 |
acute | infections | 6 |
- | stem | 6 |
- | p | 6 |
hematopoietic | transplant | 6 |
post | stem | 5 |
positive | grafts | 5 |
positive | group | 5 |
positive | t | 5 |
viral | therapy | 5 |
significant | disease | 5 |
significant | infections | 5 |
unrelated | patients | 5 |
overall | disease | 5 |
positive | donor | 5 |
specific | patient | 5 |
low | transplant | 5 |
different | risk | 5 |
high | group | 5 |
autologous | transplantations | 5 |
autologous | graft | 5 |
different | patients | 5 |
autologous | group | 5 |
different | transplant | 5 |
early | time | 5 |
first | months | 5 |
first | results | 5 |
other | therapy | 4 |
median | donor | 4 |
median | stem | 4 |
median | treatment | 4 |
older | donors | 4 |
other | blood | 4 |
other | case | 4 |
other | donor | 4 |
other | study | 4 |
primary | study | 4 |
pediatric | transplantation | 4 |
peripheral | cells | 4 |
positive | result | 4 |
primary | diseases | 4 |
immune | diseases | 4 |
significant | survival | 4 |
significant | transplant | 4 |
specific | donor | 4 |
specific | risk | 4 |
low | disease | 4 |
old | age | 4 |
immune | disease | 4 |
earlier | age | 4 |
high | groups | 4 |
- | analyses | 4 |
- | grafting | 4 |
- | groups | 4 |
- | transplants | 4 |
autologous | gvhd | 4 |
different | age | 4 |
different | studies | 4 |
different | t | 4 |
autologous | transplanted | 4 |
earlier | treatment | 4 |
first | days | 4 |
early | results | 4 |
hematopoietic | transplants | 4 |
first | transplantation | 4 |
high | donor | 4 |
first | analysis | 4 |
early | transplantation | 4 |
early | therapy | 4 |
median | patients | 3 |
non | t | 3 |
normal | blood | 3 |
normal | results | 3 |
old | patients | 3 |
other | cell | 3 |
overall | p | 3 |
pediatric | age | 3 |
pediatric | blood | 3 |
pediatric | case | 3 |
unrelated | group | 3 |
positive | groups | 3 |
positive | stem | 3 |
primary | t | 3 |
primary | transplantation | 3 |
severe | case | 3 |
significant | blood | 3 |
significant | treatment | 3 |
specific | cells | 3 |
specific | disease | 3 |
unrelated | graft | 3 |
median | year | 3 |
early | infection | 3 |
median | ages | 3 |
earlier | time | 3 |
median | % | 3 |
- | age | 3 |
- | infections | 3 |
chronic | diseases | 3 |
clinical | cases | 3 |
different | disease | 3 |
different | diseases | 3 |
different | gvhd | 3 |
different | infections | 3 |
chronic | blood | 3 |
early | graft | 3 |
low | group | 3 |
first | infection | 3 |
lowest | risk | 3 |
low | survival | 3 |
lower | disease | 3 |
immune | therapy | 3 |
higher | treatment | 3 |
high | blood | 3 |
first | therapy | 3 |
overall | survivals | 2 |
other | graft | 2 |
overall | results | 2 |
overall | result | 2 |
overall | hsct | 2 |
overall | graft | 2 |
other | results | 2 |
other | hsct | 2 |
normal | % | 2 |
other | cells | 2 |
older | donor | 2 |
normal | donor | 2 |
normal | cell | 2 |
non | transplant | 2 |
median | transplant | 2 |
pediatric | donor | 2 |
overall | transplant | 2 |
significant | group | 2 |
pediatric | studies | 2 |
significant | age | 2 |
viral | t | 2 |
unrelated | groups | 2 |
specific | therapies | 2 |
specific | studies | 2 |
specific | analysis | 2 |
lower | cell | 2 |
primary | cell | 2 |
pediatric | t | 2 |
post | therapy | 2 |
post | t | 2 |
post | graft | 2 |
positive | patient | 2 |
positive | infections | 2 |
positive | cell | 2 |
median | group | 2 |
primary | patient | 2 |
lower | % | 2 |
first | cases | 2 |
early | analysis | 2 |
earlier | study | 2 |
earlier | studies | 2 |
different | transplants | 2 |
different | transplantation | 2 |
different | survival | 2 |
different | patient | 2 |
chronic | infections | 2 |
autologous | grafts | 2 |
autologous | cells | 2 |
- | times | 2 |
- | studied | 2 |
- | donors | 2 |
- | case | 2 |
low | treatment | 2 |
first | blood | 2 |
different | study | 2 |
first | cells | 2 |
high | transplantation | 2 |
low | blood | 2 |
first | grafts | 2 |
immune | therapies | 2 |
immune | t | 2 |
immune | graft | 2 |
higher | transplant | 2 |
higher | infection | 2 |
higher | risks | 2 |
low | cell | 2 |
high | cell | 2 |
hematopoietic | diseases | 2 |
first | treatment | 2 |
first | transplants | 2 |
first | patients | 2 |
overall | time | 1 |
overall | day | 1 |
overall | group | 1 |
overall | gvhd | 1 |
overall | infections | 1 |
overall | patient | 1 |
overall | risk | 1 |
positive | treatment | 1 |
pediatric | ages | 1 |
pediatric | infection | 1 |
peripheral | cell | 1 |
positive | case | 1 |
positive | graft | 1 |
positive | infection | 1 |
post | donor | 1 |
others | diseases | 1 |
others | therapies | 1 |
median | transplantation | 1 |
other | transplantation | 1 |
other | time | 1 |
median | graft | 1 |
median | risk | 1 |
primary | donor | 1 |
non | blood | 1 |
non | transplanted | 1 |
normal | age | 1 |
normal | patients | 1 |
older | case | 1 |
older | groups | 1 |
older | patient | 1 |
older | studies | 1 |
oldest | patients | 1 |
other | age | 1 |
other | analysis | 1 |
other | gvhd | 1 |
other | infection | 1 |
other | t | 1 |
primary | analysis | 1 |
significant | risks | 1 |
primary | grafts | 1 |
specific | treatments | 1 |
specific | diseases | 1 |
specific | groups | 1 |
specific | infection | 1 |
specific | risks | 1 |
specific | stem | 1 |
specific | study | 1 |
specific | transplant | 1 |
unrelated | cases | 1 |
specific | case | 1 |
unrelated | diseases | 1 |
unrelated | transplantations | 1 |
viral | cell | 1 |
viral | groups | 1 |
viral | results | 1 |
viral | studies | 1 |
median | aged | 1 |
specific | cell | 1 |
specific | blood | 1 |
primary | patients | 1 |
severe | therapy | 1 |
primary | results | 1 |
respiratory | therapy | 1 |
severe | blood | 1 |
severe | group | 1 |
severe | groups | 1 |
severe | patients | 1 |
severe | studies | 1 |
severe | transplant | 1 |
specific | analyses | 1 |
significant | day | 1 |
significant | graft | 1 |
significant | infection | 1 |
significant | p | 1 |
significant | results | 1 |
significant | t | 1 |
significant | transplantation | 1 |
median | cells | 1 |
different | treatments | 1 |
lower | treatment | 1 |
different | results | 1 |
clinical | t | 1 |
clinical | therapy | 1 |
clinical | transplant | 1 |
clinical | treatment | 1 |
different | blood | 1 |
different | graft | 1 |
different | group | 1 |
different | risks | 1 |
clinical | infection | 1 |
different | stem | 1 |
different | therapies | 1 |
different | timed | 1 |
earlier | disease | 1 |
earlier | transplant | 1 |
earlier | transplantation | 1 |
earliest | studies | 1 |
clinical | infections | 1 |
clinical | gvhd | 1 |
lower | results | 1 |
acute | blood | 1 |
- | aged | 1 |
- | diseased | 1 |
- | months | 1 |
- | risks | 1 |
- | therapies | 1 |
- | transplantations | 1 |
- | transplanting | 1 |
acute | patients | 1 |
clinical | groups | 1 |
acute | t | 1 |
anti | gvhd | 1 |
autologous | cell | 1 |
autologous | n | 1 |
autologous | patient | 1 |
clinical | analysis | 1 |
clinical | group | 1 |
earliest | time | 1 |
early | blood | 1 |
early | case | 1 |
low | groups | 1 |
higher | day | 1 |
higher | disease | 1 |
higher | t | 1 |
immune | donor | 1 |
immune | studies | 1 |
low | cells | 1 |
low | donor | 1 |
low | gvhd | 1 |
early | days | 1 |
low | patient | 1 |
low | patients | 1 |
low | result | 1 |
low | transplantation | 1 |
lower | graft | 1 |
lower | gvhd | 1 |
lower | p | 1 |
higher | blood | 1 |
higher | age | 1 |
higher | % | 1 |
high | transplanted | 1 |
early | months | 1 |
early | study | 1 |
early | treatments | 1 |
first | disease | 1 |
first | studied | 1 |
first | t | 1 |
hematopoietic | disease | 1 |
hematopoietic | donor | 1 |
hematopoietic | hsct | 1 |
high | % | 1 |
high | case | 1 |
high | cells | 1 |
high | risks | 1 |
high | stem | 1 |
high | t | 1 |
viral | treatment | 1 |